DUBLIN--(BUSINESS WIRE)--The "United States Anesthesia Drugs Market by Type by General Inhalation by General Intravenous by Local, and Company Analysis 2025 to 2033" report has been added to ...

The US general anesthesia drugs market size is projected to reach USD 2.4 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 3.4% during the forecast. The rising prevalence of cancer, rapid ...

Paralytic drugs, or neuromuscular blocking agents (NMBAs), are powerful muscle relaxants used to prevent muscle movement during surgical procedures. They're also used during critical care, such as ...

Anesthesia on the Continent has lagged behind anesthesia in the United States.... Recently, however, a large number of Continental clinics are using intravenous anesthesia extensively not only for ...

MALVERN, Pa., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care ...

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...

Researchers offered insights into anesthesia drug costs and preoperative evaluation at the American Society of Anesthesiologists’ Practice Management 2019, Jan. 18-20 in Las Vegas, according to ...